Experimental design
| Serotype . | Route of administration/vector form . | No. of mice tested . | 
|---|---|---|
| Intraportal | ||
| 8 | 2 chains | 32 | 
| 8 | Single chain | 15 | 
| 7 | 2 chains | 21 | 
| 5 | 2 chains | 16 | 
| 2 | 2 chains | 21 | 
| 2 | Single chain | 15 | 
| Tail vein | ||
| 8 | 2 chains | 3 | 
| 8 | Single chain | 4 | 
| 2 | Single chain | 4 | 
| Serotype . | Route of administration/vector form . | No. of mice tested . | 
|---|---|---|
| Intraportal | ||
| 8 | 2 chains | 32 | 
| 8 | Single chain | 15 | 
| 7 | 2 chains | 21 | 
| 5 | 2 chains | 16 | 
| 2 | 2 chains | 21 | 
| 2 | Single chain | 15 | 
| Tail vein | ||
| 8 | 2 chains | 3 | 
| 8 | Single chain | 4 | 
| 2 | Single chain | 4 | 
AAV vector administration into FVII KO mice. Serotypes 2, 5, 7, and 8 expressing B domain-deleted canine FVIII cDNA were evaluated in hemophilia A mice. Details of the total number of mice tested, routes of vector administration, and numbers of mice receiving FVIII either in 2 vectors (heavy and light chain) or as a single-chain vector are listed.